Japan Heart Foundation   Report issue

Foundation Phase 4
Founded: Kyoto Japan (1964)

Organization Overview

First Clinical Trial
2001
NCT00265239
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Advanced-J

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 4)

Cardiovascular Diseases (Phase 4)

Coronary Artery Disease (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Hyperlipidemias (Phase 4)

Hypertension (Phase 4)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Reperfusion Injury (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 8